GM and Livent announced today a multi-year sourcing agreement in which Livent will supply GM with battery-grade lithium hydroxide manufactured from lithium obtained at its brine-based sites in South America. Lithium hydroxide is important for
GM’s plans to develop more powerful, longer-lasting electric vehicles. The batteries that will be powered by Livent’s lithium hydroxide will be used in GM’s new battery cell plant currently being built in Ohio.
GM will get battery-grade lithium hydroxide from Livent for the next 6 years. Over the term of the contract, Livent will progressively supply GM with battery-grade lithium hydroxide from its facilities in the United States, with a goal of turning 100% of Livent’s downstream lithium hydroxide processing for GM over to North America.
“We are excited to begin this long-term relationship with GM, one of the most iconic brands in the automotive industry and a leading force in the transition to electrification,” said Paul Graves, president and chief executive officer of Livent.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
GM is lining up deals to boost its EV production capacityGeneral Motors is lining up deals to shore up its long-term supply of battery materials, even as short-term supply issues continue to undermine current production.
Read more »
Millions Still Can’t Smell or Taste Six Months After COVIDResearchers say about 5 percent of patients have long-term loss of those senses.
Read more »
I Know I Should Invest My Money, But It Makes Me AnxiousMyTwoCents: 'I have about $40,000 in cash (I’m 32). I keep reading about how I should invest it for retirement, but I’m scared to do so.' CharlotteCowles responds
Read more »
Binance CEO Names Silver Lining to Crypto Bear MarketBinance’s Changpeng Zhao says that the market is healthier now compared to the peak of the most recent bull market
Read more »
A 5th person is likely cured of HIV, and another is in long-term remissionOne case involved a man with cancer who underwent a specialized stem cell transplant; the other involved a woman who received immune-boosting therapies as part of a clinical trial.
Read more »
US national debt to be double GDP by 2051, raising risk of fiscal crisis: CBOThe Congressional Budget Office said Wednesday in its latest long-term budget outlook that the U.S. federal debt is likely to rise to 185% of gross domestic product by 2051.
Read more »